| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01701622 | Blood Pressure|Gout | Drug: febuxostat | University of Mississippi Medical Center | | 2010-01-01 | 2013-02-08 |
| NCT01763996 | Coronary Artery Disease | Drug: Febuxostat|Drug: Febuxostat placebo | Takeda | Phase 4 | 2013-05-01 | 2016-03-10 |
| NCT01350388 | Chronic Kidney Disease|Diabetes | Drug: Febuxostat|Drug: Placebo | University of Utah|Takeda | | 2011-05-01 | 2016-08-09 |
| NCT01078389 | Joint Damage | Drug: Febuxostat|Drug: Placebo for Febuxostat | Takeda | Phase 2 | 2010-03-01 | 2014-09-03 |
| NCT01082640 | Renal Impairment | Drug: Febuxostat|Drug: Placebo | Takeda | Phase 2 | 2010-04-01 | 2013-09-23 |
| NCT00995618 | Gout|Hyperuricemia | Drug: Tranilast|Drug: Febuxostat|Drug: Combination - Tranilast and Febuxostat | Nuon Therapeutics, Inc. | Phase 2 | 2009-09-01 | 2011-01-05 |
| NCT01496469 | Hypertension | Drug: Febuxostat|Drug: Placebo | Takeda | Phase 2 | 2012-02-01 | 2015-07-31 |
| NCT01549977 | Angina | Drug: Febuxostat|Drug: Placebo | Takeda | Phase 2 | 2012-07-01 | 2013-10-30 |
| NCT01883167 | Healthy | Drug: RDEA3170 10 mg|Drug: Febuxostat 40 mg|Drug: placebo | Ardea Biosciences, Inc. | Phase 1 | 2013-06-01 | 2014-01-08 |
| NCT02374164 | Gout | Drug: Febuxostat XR | Takeda | Phase 1 | 2015-02-01 | 2016-03-25 |
| NCT01984749 | Hyperuricemia | Drug: Febuxostat | Freed Study Group|Teijin Pharma | | 2013-11-01 | 2016-08-25 |
| NCT02279342 | Coronary Artery Disease | Drug: Febuxostat | Yokohama City University Medical Center | Phase 4 | 2014-10-01 | 2014-10-30 |
| NCT01724528 | Tumor Lysis Syndrome | Drug: Febuxostat|Drug: Allopurinol | Menarini Group | Phase 3 | 2012-10-01 | 2014-10-27 |
| NCT01472692 | Prehypertension|Gout|Pulse Wave Velocity|Hypertension|24 Hour Blood Pressure | Drug: Febuxostat | University of California, San Diego | Phase 4 | 2011-10-01 | 2014-03-31 |
| NCT02579096 | Gout|Chronic Kidney Diseases | Drug: Allopurinol|Drug: Febuxostat|Drug: Placebo, vehicle control (Febuxostat-shaped)|Drug: Placebo, vehicle control (Allopurinol-shaped) | VA Office of Research and Development | Phase 4 | 2017-03-06 | 2017-03-24 |
| NCT02504320 | Healthy Volunteers | Drug: Febuxostat XR 80 mg Capsule F1|Drug: Febuxostat XR 80 mg Capsule F2|Drug: Febuxostat XR 80 mg Capsule F3|Drug: Febuxostat XR 80 mg Capsule F4 | Takeda | Phase 1 | 2015-08-01 | 2016-11-25 |
| NCT00102440 | Gout | Drug: Febuxostat|Drug: Febuxostat|Drug: Allopurinol | Takeda | Phase 3 | 2002-07-01 | 2012-01-31 |
| NCT02752633 | Adenine Phosphoribosyltransferase Deficiency | Drug: Allopurinol|Drug: Febuxostat | Landspitali University Hospital|Mayo Clinic|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 4 | 2013-05-01 | 2016-04-22 |
| NCT02600780 | Hyperuricemia | Drug: Febuxostat|Drug: Allopurinol | Getz Pharma | Phase 4 | 2013-11-01 | 2015-11-06 |
| NCT02338323 | Chronic Kidney Disease|Hyperuricemia|Abnormal Renal Function | Drug: Febuxostat|Drug: Benzbromarone | Shanghai 10th People's Hospital | | 2015-01-01 | 2016-05-05 |
| NCT01101035 | Cardiovascular Disease | Drug: Febuxostat|Drug: Allopurinol | Takeda|Teijin America, Inc. | Phase 3 | 2010-04-01 | 2016-08-17 |
| NCT00174915 | Gout | Drug: Febuxostat|Drug: Febuxostat|Drug: Febuxostat|Drug: Allopurinol|Drug: Placebo | Takeda | Phase 3 | 2003-02-01 | 2012-01-31 |
| NCT02944214 | Chronic Kidney Disease|Hyperuricemia|Abnormal Renal Function | Drug: Febuxostat|Drug: Benzbromarone | Shanghai 10th People's Hospital | | 2016-10-01 | 2016-10-24 |
| NCT00175019 | Gout | Drug: Febuxostat|Drug: Febuxostat|Drug: Allopurinol | Takeda | Phase 3 | 2003-07-01 | 2010-07-22 |
| NCT01077284 | Hyperuricosuria|Kidney Stones | Drug: Febuxostat|Drug: Allopurinol|Drug: Placebo | Takeda | Phase 2 | 2010-02-01 | 2013-01-14 |
